Published in
Oxford University Press (OUP), Cardiovascular Research, 13(113), p. 1585-1602
DOI: 10.1093/cvr/cvx165
Links
Tools
A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration
Journal article published in 2017 by
Chahua Huang,
Yang Liu,
Andrew Beenken,
Lin Jiang,
Xiang Gao,
Zhifeng Huang,
Anna Hsu,
Garrett J. Gross,
Yi-Gang Wang,
Moosa Mohammadi,
Jo El J. Schultz
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
